Viking Therapeutics taps CordenPharma to manufacture its obesity drugsnews2025-03-12T13:43:22+00:00March 12th, 2025|Endpoints News|
Legend to double Carvykti production as it targets blockbuster status news2025-03-12T11:19:37+00:00March 12th, 2025|Endpoints News|
Ono licenses rare blood disease drug from Ionis for $280M upfrontnews2025-03-12T10:34:49+00:00March 12th, 2025|Endpoints News|
Updated: Zealand partners with Roche on its amylin analog in a deal worth up to $5.3Bnews2025-03-12T08:10:30+00:00March 12th, 2025|Endpoints News|
FDA review departments largely spared from Musk-led cutsnews2025-03-11T19:21:01+00:00March 11th, 2025|Endpoints News|
Merck dodges ‘failure to warn’ claims in federal Gardasil casesnews2025-03-11T17:39:19+00:00March 11th, 2025|Endpoints News|
Gilead plans to skip from Phase 1 to Phase 3 with once-yearly PrEP drugnews2025-03-11T17:37:42+00:00March 11th, 2025|Endpoints News|
Mineralys aims to raise $250M; Coherus discloses layoffsnews2025-03-11T15:07:51+00:00March 11th, 2025|Endpoints News|
Endo sells international business for $84Mnews2025-03-11T14:26:38+00:00March 11th, 2025|Endpoints News|
